UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000009300
Receipt number R000010920
Scientific Title Exploratory research of predictive factors in randomized phase 2 study comparing maintenance treatments with paclitaxel plus bevacizumab and endocrine agent in patients with inoperable or recurrent breast cancer who received prior endocrine treatment and achieved non progressive disease during induction treatment with paclitaxel plus bevacizumab.
Date of disclosure of the study information 2012/11/12
Last modified on 2019/05/17 16:02:47

No. Disposal Last modified on Item of update
1 Insert 2012/11/09 17:16:46
2 Update 2013/11/13 08:53:51 Public title
Public title
3 Update 2013/11/13 08:55:45 Narrative objectives1
Narrative objectives1
4 Update 2013/11/13 08:57:15 Email
5 Update 2017/11/15 07:45:52 Name of primary person or sponsor
Organization
Email1
6 Update 2018/09/26 14:03:17 Recruitment status
7 Update 2019/05/15 18:03:35 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
Zip code
Address

Last name of contact person

Last name of contact person
Zip code
Address
Email1
Organization
Organization
Address
Address
Tel
Email
8 Update 2019/05/17 16:02:47 Recruitment status
Date of IRB
Last follow-up date